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ABSTRACT
Rapid identification of the etiological agent in bacterial infection is necessary for correct diagnosis and appropriate 
therapy. In general, identification of pure cultures of bacteria using conventional phenotyping techniques requires 4-24 
hours. Recently available new molecular technologies offer the potential of same day species identification once pure 
culture is available. Our aim was to evaluate the performance of rDNA V1 hypervariable region pyrosequencing, and 
the whole cell MALDI-TOF MS protein profiling in routine species identification. During the period from June 2012 to 
June 2014, 1.140 pure culture isolates were recovered from 402 samples from 126 patients suffering cystic fibrosis, 
chronic obstructive pulmonary disease or bronchiectasis. All the isolates were subjected to species identification by both 
techniques. Unfortunately, pyrosequencing was able to reach the species level in 43.2% of isolates only, whereas MAL-
DI-TOF was clearly superior with 96.8% respectively. The overall sensitivity values also clearly underlined the superiority 
of MALDI-TOF MS with 96.8% compared to 85.1% achieved by pyrosequencing. Generally, MALDI-TOF MS turned out 
to be the best suitable technique in routine bacterial identification, whereas pyrosequencing could be recommended as 
the method of choice particularly in situations where MALDI-TOF MS fails to identify rare species.
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INTRODUCTION
For clinical practice it is crucial to define the infectious agent as 
quickly and precisely as possible. Especially severe and rapid progressive 
diseases such as sepsis with high mortality rates need to be diagnosed 
properly and without latency. Molecular techniques based on direct 
detection of a particular gene using typically PCR combined with probe 
hybridization or sequencing may solve this extremely important medical 
problem [1,2,3]. However, conventional routine bacterial identification 
still relies on cultivation followed by identification of pure culture in 
most of the other samples. The rationale of this is not only the economy 
and high throughput of cultivation, but also frequent need of phenotypic 
antibiotic susceptibility testing on pure culture. Therefore, species iden-
tification techniques that are universally applicable on pure cultures of 
a wide spectrum of bacteria will most probably continue to prevail in 
routine diagnostic laboratories in the foreseeable future. In the recent 
years, whole cell MALDI-TOF MS profiling has been implemented in 
most diagnostic laboratories [2]. Next-generation sequencing that offers 
reduced costs compared to traditional Sanger sequencing, represents 
another potentially broadly applicable alternative.
The matrix assisted laser desorption/ionization-time of flight mass 
spectrometry (MALDI-TOF MS) identification is based on individual 
characteristic patterns of highly abundant proteins that are found in all 
microorganisms. The detected pattern is being matched with an extensive 
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open database, which allows for reliable and accurate identification of 
the particular microorganism [4,5].
The pyrosequencing is a powerful sequencing and quantification 
platform for microbial identification, which could namely be positively 
influenced by proper and adequate selection of the individual examined 
DNA region [6,7]. For economic reasons, however, not more than 1 
or 2 regions can be sequenced to keep costs competitive compared to 
MALDI-TOF MS. The aim of this study was to evaluate the performance 
of a single pyrosequencing reaction targeting the V1 hypervariable 
region of the 16S rRNA gene in quasi-routine settings, compared to 
routine MALDI-TOF MS protein profiling.
MATERIALS AND METHODS
During the period from June 2012 to June 2014, 402 respiratory 
pathways samples obtained from 126 patients suffering chronic lung 
disease (cystic fibrosis, bronchiectasis and chronic obstructive pulmonary 
disease) were collected. Primary cultivation was done on Columbia 
blood agar (Oxoid) and Haemophilus selective agar (Oxoid) at 37°C in 
5% CO2 atmosphere; on McKay agar (Oxoid) at 37°C under anaerobic 
condition (80% N2, 10% H2, 10% CO2); and on Burkholderia cepacia 
agar (Oxoid) at 30°C in ambient air, yielding 1.140 clinical isolates of 
bacteria altogether. The obtained isolates were accompanied by 8 ref-
erence strains (Burkholderia multivorans LMG 13010, B. cenocepacia 
LMG 16656, Enterococcus faecalis CCM 4224, Escherichia coli CCM 
3954, Pseudomonas aeruginosa CCM 3955, Staphylococcus aureus CCM 
3953 and CCM 4223, Streptococcus mitis CCM 7411 and S sanguinis 
CCM 4047) for functional verification of the methods.
Whole cell MALDI-TOF MS protein profiling was performed on 
a Microflex LT/SH system (Bruker, Germany) with HCCA matrix 
(α-Cyano-4-hydroxycinnamic acid, Sigma-Aldrich). A MALDI Bio-
typer software was used for species identification in accordance with 
manufacturer’s instruction. Template DNA was extracted using Patho-
genFree DNA PCR Kit (GeneProof, Czech Republic) according to the 
manufacturer’s instructions. The V1 hypervariable region of the 16S 
rDNA was amplified using primers bio-pBR5`.SE and pBR-V1.AS [7]. 
Briefly, the 25 µl reaction mixture consisted of 12.5 µl 2 × PyroMark 
PCR master mix (Qiagen, Germany), 1 µl of LCGreen dye 10 × (fi-
nal concentration 0.4 ×, Idaho Technology, USA), 0.1 µl of forward 
(bio-pBR5`.SE) and reverse primers (pBR-V1.AS; 0.4 µmol/l final 
concentration each) and 2 µl of DNA template. PCR was performed in 
a LightCycler 96 instrument under the following cycling parameters: 
initial denaturation at 95°C for 15 min; 45 cycles of 94°C for 30 s, 56°C 
for 30 s and 72°C for 30 s; followed by final extension at 72°C for 10 
min. Pyrosequencing was performed on a PyroMark Q96 ID instrument 
(Qiagen, Germany) using the PyroMark Gold Q96 Reagents (Qiagen, 
Germany) following manufacturer’s instructions. Briefly, 20 µl of 
amplified DNA products were mixed with 3 µl Streptavidin sepharose 
beads (GE Healthcare Life Sciences, Sweden), 40 µl of binding buffer 
(Qiagen, Germany) and 17 µl of deionised water, followed by shaking 
at 1,400 rpm for at least 10 min. Then, the immobilized complex of PCR 
products-Streptavidin sepharose beads was captured using a Vacuum 
Prep Workstation (Qiagen, Germany). Single strand purification was 
achieved by successive washing with 70% ethanol, denaturation buffer 
(Qiagen, Germany) and washing buffer (Qiagen, Germany), for 10 s 
each. Through this step, the non-biotinylated strand was dissociated 
and discarded. The sepharose beads with biotinylated strand were then 
released into a 96-well plate that was pre-filled with 40 µl of sequencing 
primer diluted in annealing buffer at 0.4 mmol/l final concentration. 
The plate was incubated at 80°C for 2 min, followed by slow cooling 
to room temperature. Then the plate was loaded into a PyroMark Q96 
ID system instrument with the PyroMark Q96 application software 1.0 
(Qiagen, Germany) set on 25 cycles of ATCG dispenses. The resulting 
sequences were compared with sequences in the Genbank database 
using BLAST tool provided on-line by NIH (http://blast.ncbi.nlm.nih.
gov/Blast.cgi), Basic Local Alignment Search Tool.
Performance of the two identification techniques was evaluated using 
three parameters. Identification depth was calculated as the percentage 
of isolates identified to species level by a particular technique (isolates 
identified to species level/total number of isolates). Sensitivity was cal-
culated as the percentage of unambiguous results of identification (either 
species or genus), i.e. number of unambiguous identification results 
(species or genus level) divided by the total number of isolates tested 
by particular technique. Specificity was calculated as the percentage 
of isolates where incorrect identification was excluded (no incorrect 
species or genus identification was issued by a particular technique). The 
correctness of the identification was indicated by the MALDI Biotyper 
score and e-value of pyrosequencing.
RESULTS AND DISCUSSION
Results of identification level achieved by the tested techniques are 
summarized in Table 1. We were not able to identify 8 clinical isolates 
by either of the techniques. The specificity of both methods reached 
100%, i.e. if any of them issued a result, it was never incorrect. However, 
their performance in terms of identification depth was fairly different. 
Pyrosequencing was able to reach the species level in 43.2% of isolates 
only, whereas MALDI-TOF was clearly superior by achieving species 
level identification in 96.8% of the isolates tested. The overall sensitivity 
values also clearly underlined the superiority of MALDI-TOF MS with 
96.8% compared to 85.1% achieved by pyrosequencing (some of the 
isolates were identified neither to species, nor genus level, just higher 
taxa, which was evaluated as insufficient and thus decreased the sen-
sitivity value). Obviously, variability of the initial part of V1 region in 
the 16S rDNA detected by pyrosequencing is not sufficient enough for 
broad-range identification of several bacterial species. In our study, length 
of successfully sequenced portion of the V1 region varied extensively, 
namely between 9 and 144 nucleotides with median of 48 nucleotides. 
Then, insufficient depth and sensitivity of identification should be due 
to the shorter read length, as reported also by others [8,9,10]. According 
to some authors, combined pyrosequencing results from the regions 
V1 and V3 or V6 could be more beneficial [7,10]. Unfortunately, this 
would further increase the running costs of pyrosequencing compared 
to MALDI-TOF MS in routine use.
On the other hand, due to an extensive database of DNA sequences 
available in GenBank, pyrosequencing proved to be more suitable for 
the identification of rare species not yet included in the commercial 
MALDI-TOF MS database. For example, MALDI-TOF MS com-
pletely failed to identify Asaia bogorensis, which was successfully and 
unequivocally achieved by pyrosequencing. Notably, this species was 
recovered on Burkholderia cepacia selective agar, indicating possible 
initial infection by a serious pathogen in cystic fibrosis settings. When 
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MALDI-TOF identification fails in such case, correct identification 
should be achieved without unnecessary delay. Then, pyrosequencing 
represents a rapid and economic alternative to full Sanger sequencing. 
Interestingly, Asaia sp. was recently described to contaminate and 
decay fruit-flavoured drinks [11]. Most probably, this species just 
transiently colonized patients’ respiratory pathways after drinking 
spoiled beverages, because later, it was never recovered again. Thus, 
pyrosequencing resolved this puzzling culture result without the need 
to start a Burkholderia sp. eradication attempt. Further, Variovorax sp. 
that was already detected in hospital environment in CF patient samples 
[12] also posed an insurmountable problem for MALDI-TOF, whereas 
V1 pyrosequencing was able to identify the genus. MALDI-TOF also 
performed inferior to pyrosequencing in Granullicatella adiacens, 
where 6 of the 13 strains were not identified by MALDI-TOF MS to 
species level, whereas all of them were successfully identified by V1 
pyrosequencing. Similarly, one Staphylococcus pasteuri strain, and, more 
importantly, one Pseudomonas aeruginosa strain were not identified to 
species level by MALDI-TOF MS in contrast to V1 pyrosequencing.
Table 1. List of species and results of identification by MALDI-TOF MS and pyrosequencing.
Species Number of 
isolates
Highest level of identification achieved
MALDI-TOF MS pyrosequencing
Acinetobacter baumannii, calcoaceticus, pittii, ursingii 6 species genus
Actinomyces oris 5 species species
Aggregatibacter aphrophilus, segnis 12 species group 1*
Achromobacter ruhlandii, spanius, xylosoxidans 12 species genus
Asaia bogorensis 1 none species
Bacillus licheniformis 2 species none
Bacillus pumilus 3 species species
Bordetella bronchiseptica 3 species genus
Brevibacterium casei 2 species none
Burkholderia cepacia complex (B. cenocepacia, cepacia sensu stricto, 
multivorans)
28 species complex
Citrobacter freundii 2 species species
Corynebacterium amycolatum, aurimucosum, durum, matrochotii, propin-
quum, pseudodiphteriticum, striatum
20 species genus
Cupriavidus metallidurans 4 species species
Delftia acidovorans 2 species species
Eikenella corrodens 1 species species
Enterobacter asburiae, aerogenes, cloacae, kobei, ludwigii 11 species group 2**
Enterococcus faecalis 5 species species
Erwinia persicina 1 species genus
Escherichia coli 4 species species
Gemella haemolysans, sanguinis 16 species none
Granulicatella adiacens 13 species (7)/none (6) species
Haemophilus haemolyticus, influenzae 83 species group 1*
Haemophilus parahaemolyticus 1 species none
Haemophilus parainfluenzae 127 species species
Haemophilus pittmaniae 1 species genus
Chryseobacterium hominis 1 species none
Kingella denitrificans 5 species species
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Table 1 (Continued).
Species Number of 
isolates
Highest level of identification achieved
MALDI-TOF MS pyrosequencing
Lactobacillus casei, paracasei 8 species genus
Lactobacillus fermentum, plantarum, rhamnosus, salivarius 16 species species
Lactobacillus gasseri 1 species genus
Lactobacillus kimchii 1 species none
Lactococcus lactis 1 species none
Micrococcus luteus 1 species species
Moraxella catarrhalis, liquefaciens, nonliquefaciens 15 species genus
Neisseria flavescens, macacae 4 species genus
Neisseria oralis 1 none species
Ochrobactrum tritici 2 species none
Pannonibacter phragmitetus 2 species species
Proteus mirabilis, vulgaris 7 species group 1*
Pseudomonas aeruginosa 127 species (126)/none (1) species
Pseudomonas grimontii, mendocina, veronii 16 species genus
Ralstonia pickettii 3 species species
Rhizobium radiobacter 1 species family
Rhodococcus kroppenstedtii 1 species genus
Rothia aeria 8 species genus
Rothia dentocariosa, mucilaginosa 26 species species
Serratia marcescens 3 species species
Staphylococcus aureus, cohnii, epidermidis, hominis 70 species species
Staphylococcus pasteuri 1 none species
Stenotrophomonas maltophilia 19 species species
Streptococcus agalactiae, infantis, massiliensis, oligofermentans, 
parasanguinis
51 species (48)/none (3) species
Streptococcus anginosus, constellatus, dysgalactiae, gordonii, interme-
dius, mitis, oralis, peroris, pneumoniae, pyogenes, salivarius, sanguinis, 
vestibularis
351 species (339)/none (12) genus (350)/none (1)
Streptococcus mutans 5 species none
Streptomyces scabiei, griseus 2 species genus
Variovorax 2 none genus
Not identified 8 none none
*Group 1 included genera Aggregatibacter, Haemophillus (haemolyticus and influenzae) and Proteus. **Group 2 included genera Enterobacter and Klebsiella.
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CONCLUSIONS
Generally, MALDI-TOF MS turned out to be the best suitable 
technique in routine bacterial identification for its easy and economic 
performance and low labour costs. In contrast, V1 region pyrosequenc-
ing failed as general routine technique, although it offered an economic 
opportunity for rare species identification not yet included in the data-
base of protein profiles. With time, on the other hand, extended length 
reading at lower costs can be expected due to technical improvements 
in future, which may improve the performance and application potential 
of pyrosequencing. For the moment, however, pyrosequencing could 
be recommended as the method of choice only in situations where 
MALDI-TOF MS goes wrong. 
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